Pages that link to "Q48289094"

The following pages link to Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease (Q48289094):

Displaying 44 items.

• Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration (Q28215001) (← links)
• Neuroimaging and therapeutics in movement disorders (Q30989947) (← links)
• The role of biomarkers and imaging in Parkinson's disease. (Q31041660) (← links)
• Surgical options in Parkinson's disease (Q33545304) (← links)
• Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications (Q33708288) (← links)
• Clinicopathological study of 35 cases of multiple system atrophy. (Q33733668) (← links)
• FDG PET in the Evaluation of Parkinson's Disease (Q34035765) (← links)
• Multiple system atrophy: pathophysiology and management (Q34432121) (← links)
• Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease (Q34510415) (← links)
• The nature of the autonomic dysfunction in multiple system atrophy (Q34750134) (← links)
• The pathophysiology of parkinsonism in multiple system atrophy (Q35055565) (← links)
• Functional brain imaging in the differential diagnosis of Parkinson's disease (Q35751834) (← links)
• Network correlates of disease severity in multiple system atrophy (Q35883193) (← links)
• Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease (Q36314846) (← links)
• Cerebral mitochondrial metabolism in early Parkinson's disease (Q37001813) (← links)
• Assessment of Parkinson's disease with imaging. (Q37082034) (← links)
• Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes (Q37185684) (← links)
• Proposed neuroimaging criteria for the diagnosis of multiple system atrophy (Q37420656) (← links)
• Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease. (Q37687353) (← links)
• PET/CT in diagnosis of movement disorders (Q37896142) (← links)
• Positron emission tomography neuroimaging in Parkinson's disease (Q37929598) (← links)
• Biomarkers for trials of neuroprotection in Parkinson's disease (Q38038544) (← links)
• Controversies in Pallidal Surgery (Q41542197) (← links)
• Positron Emission Tomography Studies in Movement Disorders (Q41718477) (← links)
• PET studies of cerebral metabolism in Parkinson disease (Q43244605) (← links)
• Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. (Q43938517) (← links)
• Cerebral metabolic changes in early multiple system atrophy: a PET study (Q44071363) (← links)
• Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease (Q46418678) (← links)
• Abnormal metabolic networks in atypical parkinsonism (Q46815002) (← links)
• A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Q48147177) (← links)
• Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy (Q48176438) (← links)
• Quantification of Parkinson's disease-related network expression with ECD SPECT. (Q48374366) (← links)
• Increased Basal Ganglia Iron in Striatonigral Degeneration: In Vivo Estimation with Magnetic Resonance (Q48494432) (← links)
• Differentiating between multiple system atrophy and Parkinson’s disease by positron emission tomography with18F-dopa and18F-FDG (Q48641864) (← links)
• Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study (Q48845453) (← links)
• The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy (Q48866922) (← links)
• [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration (Q51371295) (← links)
• Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. (Q53112545) (← links)
• Imaging Parkinson's disease (Q57088817) (← links)
• PET Imaging in Movement Disorders (Q57456370) (← links)
• Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease (Q64785265) (← links)
• Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging (Q71676882) (← links)
• Pallidotomy for Parkinson's Disease (Q72110838) (← links)
• The metabolic topography of parkinsonism (Q72136177) (← links)